Displaying 1 - 50 of 158 results
Released Company Title Industry Topic
29 Apr 2021
16:15 CEST
SOFTOX SOLUTIONS SoftOx Solutions AS Q1-2021 Presentation 20103010 Biotechnology Non-regulatory press releases
29 Apr 2021
07:00 CEST
SOFTOX SOLUTIONS SoftOx Solutions AS: First Quarter 2021 Results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
26 Apr 2021
13:58 CEST
SOFTOX SOLUTIONS Presentation of SoftOx Solution AS First quarter 2021 Results 20103010 Biotechnology Non-regulatory press releases
13 Apr 2021
19:46 CEST
SOFTOX SOLUTIONS SoftOx Solutions AS: Protokoll fra generalforsamling 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
09 Apr 2021
08:00 CEST
SOFTOX SOLUTIONS SOFTOX SOLUTIONS AS: NATIONAL COMMITTEE ON HEALTH RESEARCH ETHICS APPROVES FIRST-IN-HUMAN CLINICAL STUDY FOR SOFTOX WOUND TREATMENT AGENT FOR CHRONIC WOUNDS, BIOFILM ERADICATOR (SBE) 20103010 Biotechnology Non-regulatory press releases
06 Apr 2021
09:00 CEST
SOFTOX SOLUTIONS SOFTOX SOLUTIONS AS: NOTICE OF ANNUAL GENERAL MEETING 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Apr 2021
08:45 CEST
SOFTOX SOLUTIONS SoftOx Solutions AS: Annual Report 2020 20103010 Biotechnology Annual financial and audit Reports
29 Mar 2021
14:32 CEST
SOFTOX SOLUTIONS SoftOx Solutions AS: The Swedish Chemicals Agency rejected the application for approval of SoftOx Disinfection Products – requesting more data, - can lead to six months delay 20103010 Biotechnology Inside information
23 Mar 2021
15:49 CET
SOFTOX SOLUTIONS SOFTOX SOLUTIONS AS HAS COMPLETED ENROLMENT OF SOFTOX WOUND IRRIGATION SOLUTION CONFIRMATORY STUDY (SWIS-02) 20103010 Biotechnology Non-regulatory press releases
22 Mar 2021
08:30 CET
SOFTOX SOLUTIONS SoftOx Solutions AS and the Norwegian Defense Research Establishment (FFI) have entered into a collaboration agreement 20103010 Biotechnology Non-regulatory press releases
17 Mar 2021
10:05 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: New share capital registered 20103010 Biotechnology Total number of voting rights and capital
16 Mar 2021
13:53 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: New share capital registered 20103010 Biotechnology Total number of voting rights and capital
15 Mar 2021
08:30 CET
SOFTOX SOLUTIONS SOFTOX SOLUTIONS AS: DANISH MEDICINES AGENCY APPROVES FIRST-IN-HUMAN CLINICAL STUDY FOR SOFTOX WOUND TREATMENT AGENT FOR INFECTIONS IN CHRONIC WOUNDS, BIOFILM ERADICATOR (SBE) 20103010 Biotechnology Non-regulatory press releases
04 Mar 2021
12:28 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Final result of Subsequent Offering 20103010 Biotechnology Mandatory notification of trade primary insiders
03 Mar 2021
20:00 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Preliminary result of the Subsequent Offering 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Mar 2021
08:00 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Last day of the subscription period in the Subsequent Offering 20103010 Biotechnology Non-regulatory press releases
01 Mar 2021
10:37 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Share issuance to employees 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Feb 2021
18:38 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: The following is reported from primary insider Claus Seeberg 20103010 Biotechnology Mandatory notification of trade primary insiders
24 Feb 2021
20:50 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Share issuance to employees 20103010 Biotechnology Mandatory notification of trade primary insiders
24 Feb 2021
08:30 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: The following is reported from primary insiders of SoftOx Solutions AS 20103010 Biotechnology Mandatory notification of trade primary insiders
16 Feb 2021
14:53 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: National Prospectus registered and commencement of subscription period in the subsequent offering 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Feb 2021
15:17 CET
SOFTOX SOLUTIONS SoftOx Solutions AS - Information regarding the repair offering 20103010 Biotechnology Non-regulatory press releases
09 Feb 2021
08:45 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Fourth Quarter 2020 Results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Feb 2021
08:17 CET
SOFTOX SOLUTIONS Finansiell kalender 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
09 Feb 2021
08:17 CET
SOFTOX SOLUTIONS Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Feb 2021
08:30 CET
SOFTOX SOLUTIONS SoftOx Solutions AS og Forsvarets Forskningsinstitutt (FFI) inngår intensjonsavtale 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
03 Feb 2021
08:30 CET
SOFTOX SOLUTIONS SoftOx Solutions AS and the Norwegian Defence Research Establishment (FFI) sign letter of intent 20103010 Biotechnology Non-regulatory press releases
02 Feb 2021
20:25 CET
SOFTOX SOLUTIONS SoftOx Solutions AS: Exercise of share options and share capital increase 20103010 Biotechnology Mandatory notification of trade primary insiders
15 Jan 2021
11:25 CET
SoftOx Solutions SoftOx Solutions AS: New share capital registered 20103010 Biotechnology Total number of voting rights and capital
04 Jan 2021
13:55 CET
SoftOx Solutions SoftOx Solutions AS: Protokoll fra ekstraordinær generalforsamling 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
04 Jan 2021
12:06 CET
SoftOx Solutions SoftOx Solutions AS: Følgende rapporteres fra Primærinnsider Harefrøken Invest AS (Investeringsselskap eid av Helene Ihlen, CEO Geir Almås samboer) – tildelingen er ubetinget 20103010 Biotechnology Meldepliktig handel for primærinnsidere
04 Jan 2021
12:06 CET
SoftOx Solutions SoftOx Solutions AS: The following is reported from Primary Insider Harefrøken Invest AS (Investment company owned by Helene Ihlen, partner of CEO Geir Almås) - the award is unconditional 20103010 Biotechnology Mandatory notification of trade primary insiders
28 Dec 2020
17:14 CET
SoftOx Solutions SoftOx Solutions AS: Innkalling til ekstraordinær generalforsamling 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
28 Dec 2020
17:14 CET
SoftOx Solutions SoftOx Solutions AS: Notice of extraordinary general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
24 Dec 2020
12:10 CET
SoftOx Solutions SoftOx Solutions AS: New share capital registered 20103010 Biotechnology Total number of voting rights and capital
24 Dec 2020
12:10 CET
SoftOx Solutions SoftOx Solutions AS: Ny aksjekapital registrert 20103010 Biotechnology Kapital- og stemmerettsendringer
21 Dec 2020
10:54 CET
SoftOx Solutions Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Dec 2020
10:54 CET
SoftOx Solutions Finansiell kalender 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
21 Dec 2020
10:25 CET
SoftOx Solutions SoftOx Solutions AS melder om ny distribusjonskanal 20103010 Biotechnology Innsideinformasjon
21 Dec 2020
10:25 CET
SoftOx Solutions SoftOx Solutions AS announces new distribution agreement 20103010 Biotechnology Inside information
20 Dec 2020
21:07 CET
SoftOx Solutions SoftOx Solutions AS: Følgende rapporteres fra Primærinnsider Harefrøken Invest AS (Investeringsselskap eid av Helene Ihlen, CEO Geir Almås samboer) 20103010 Biotechnology Meldepliktig handel for primærinnsidere
20 Dec 2020
21:07 CET
SoftOx Solutions SoftOx Solutions AS: The following is reported from Primary Insider Harefrøken Invest AS (Investment company owned by Helene Ihlen, partner of CEO Geir Almås) 20103010 Biotechnology Mandatory notification of trade primary insiders
18 Dec 2020
09:53 CET
SoftOx Solutions SoftOx Solutions AS: Hentet NOK 50 millioner etter børs onsdag 16.12 – Mer enn 100% overtegnet 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
18 Dec 2020
09:53 CET
SoftOx Solutions SoftOx Solutions AS: Raised NOK 50 million after stock exchange closing Wednesday December 16th - More than 100% oversubscribed 20103010 Biotechnology Non-regulatory press releases
16 Dec 2020
23:29 CET
SoftOx Solutions SoftOx Solutions AS: Key information relating to the repair issue to be carried out by SoftOx Solutions AS 20103010 Biotechnology Ex Date
16 Dec 2020
23:21 CET
SoftOx Solutions SoftOx Solutions AS: Private placement successfully completed 20103010 Biotechnology Inside information
16 Dec 2020
16:30 CET
SoftOx Solutions SoftOx Solutions AS: Contemplated private placement 20103010 Biotechnology Inside information
16 Dec 2020
09:35 CET
SoftOx Solutions Københavns Universitet og SoftOx Solutions rapporterer om positive resultater med SoftOx Inhalation Solution (SIS) 20103010 Biotechnology Innsideinformasjon
16 Dec 2020
09:35 CET
SoftOx Solutions University of Copenhagen and SoftOx Solutions reports on positive results on SoftOx Inhalation Solution (SIS) 20103010 Biotechnology Inside information
16 Dec 2020
09:00 CET
SoftOx Solutions SoftOx announces co-operation with new distributor 20103010 Biotechnology Non-regulatory press releases